- Insider Monkey•20 hours agoManufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories. This will also have an impact on the Cambridge, Massachusetts-based Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), which is seeking collaboration with Novartis AG (ADR) (NYSE:NVS) subsidiary Sandoz on the generic drug. Of course, […]
- Investor's Business Daily•2 days ago
Momenta and Pfizer are unexpectedly giving Teva some breathing room on a generic version of MS drug Copaxone.
- Motley Fool•2 days ago
The drugmaker announced a delay to approval of its three-times-weekly version of Glatopa.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Day's Range||35.74 - 36.13|
|52 Week Range||31.90 - 59.35|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||20.97|
|Dividend & Yield||1.36 (3.71%)|
|1y Target Est||N/A|